At the news
? NEUTRALIMPACT 3/10 144 filed Apr 10, 2026 at 16:11 ET
Nagendran Sukumar, an officer of Taysha Gene Therapies, filed a Form 144 to notify intent to sell up to 200,000 shares of common stock, valued at approximately $942,740, under a 10b5-1 selling plan adopted on June 11, 2025. The sale is scheduled for January 12, 2026.
- Reporting person: Nagendran Sukumar, officer of TSHA
- Number of shares proposed for sale: 200,000
- Approximate value of shares: $942,740
- Sale date: January 12, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access